Literature DB >> 3806054

Characteristics of the developmental cycle of actinophage phi C31.

A Rodríguez, J L Caso, C Hardisson, J E Suárez.   

Abstract

Some characteristics of the lytic development of the temperate phage phi C31 in Streptomyces coelicolor A3(2) were studied using a thermoinducible lysogen. The physiological state of the host and the culture medium influenced the production of progeny virus after induction. The latent period lasted 45 min and the rise period 20-30 min. RNA synthesis in induced cultures was reduced with respect to controls. This reduction was restricted to cellular transcription as evidenced by: no stable RNA being synthesized in induced cultures, and the proportion of phage specific RNA increasing from 0.5% before induction to more than 30% in induced cultures. Host RNA synthesis proceeded throughout the lytic cycle. Protein synthesis was also reduced in induced cultures, although to a lesser extent than RNA synthesis. Phage DNA synthesis started at around 10 min postinduction, marking the division between the early and late periods of phage development. Host DNA synthesis occurred during the first 20 min after induction, and gradually decreased later.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3806054     DOI: 10.1099/00221287-132-6-1695

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  3 in total

1.  Isolation and characterization of two types of actinophage infecting Streptomyces scabies.

Authors:  el-S A el-Sayed; G el-Didamony; K Mansour
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

2.  The repressor gene (c) of the Streptomyces temperate phage phi c31: nucleotide sequence, analysis and functional cloning.

Authors:  R B Sinclair; M J Bibb
Journal:  Mol Gen Genet       Date:  1988-08

3.  Characterization of a late promoter from the Streptomyces temperate phage phi C31.

Authors:  C W Howe; M C Smith
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.